| Literature DB >> 33572481 |
Kristoffer Kjærgaard1, Anne Catrine Daugaard Mikkelsen1, Charlotte Wilhelmina Wernberg2, Lea Ladegaard Grønkjær2, Peter Lykke Eriksen1, Malene Flensborg Damholdt3,4, Rajeshwar Prosad Mookerjee1,5, Hendrik Vilstrup1, Mette Munk Lauridsen2, Karen Louise Thomsen1,5.
Abstract
Non-alcoholic fatty liver disease (NAFLD) has emerged as the hepatic component of the metabolic syndrome and now seemingly affects one-fourth of the world population. Features associated with NAFLD and the metabolic syndrome have frequently been linked to cognitive dysfunction, i.e. systemic inflammation, vascular dysfunction, and sleep apnoea. However, emerging evidence suggests that NAFLD may be a cause of cognitive dysfunction independent of these factors. NAFLD in addition exhibits dysbiosis of the gut microbiota and impaired urea cycle function, favouring systemic ammonia accumulation and further promotes systemic inflammation. Such disruption of the gut-liver-brain axis is essential in the pathogenesis of hepatic encephalopathy, the neuropsychiatric syndrome associated with progressive liver disease. Considering the growing burden of NAFLD, the morbidity from cognitive impairment is expected to have huge societal and economic impact. The present paper provides a review of the available evidence for cognitive dysfunction in NAFLD and outlines its possible mechanisms. Moreover, the clinical challenges of characterizing and diagnosing cognitive dysfunction in NAFLD are discussed.Entities:
Keywords: ammonia; cognition; hepatic encephalopathy.; inflammation; neurodegeneration; neuropsychology; non-alcoholic steatohepatitis; psychometric; vascular dysfunction
Year: 2021 PMID: 33572481 PMCID: PMC7916374 DOI: 10.3390/jcm10040673
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241